EB
Emergent BioSolutions Inc.
EBS · NYSE
$6.23 +6.05% (+$0.36)
1M +35.73%
Market Cap $303.4M
P/E Ratio -
Div. Yield -
ROE 35.91%
Bulios Fair Price
$3.13
49.7% downside
Trenutna cena
$6.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EBS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/S 0.39x
P/B 0.89x
P/FCF 3.53x
Growth
0 /100
Declining Rev. growth 12.72%
Book val. growth 27.79%
EPS growth N/A
Profitability
41 /100
Moderate Gross margin 49.40%
Net margin 22.96%
FCF margin 11.15%
Quality
9 /100
Poor ROIC 6.87%
ROE 35.91%
Asset turnover 0.69x
Debt
36 /100
Moderate Debt/Equity 1.70x
Current ratio 5.42x
Int. coverage -1.87x
Stability
25 /100
Unstable Beta 2.34x
Rev. volatility 14.98%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EBS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joseph C. Papa Jr.
Employees
900
Headquarters
Gaithersburg
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report